Generic empagliflozin and linagliptin 10 mg/5 mg film-coated tablet, Empagliflozin and Linagliptin Tablets 10 mg/5 mg,,Empagliflozin and linagliptin 10 mg/5 mg film-coated tablets, Glyxambi 10 mg/5 mg
Sponsors
International Bio Service Co., Ltd.
Conditions
Bioequivalence study in healthy Thai volunteers
Empagliflozin and Linagliptin Bioequivalence study, Healthy
Phase 1
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Fixed-dose Combination of Empagliflozin and Linagliptin 10/5 mg FCT (Empagliflozin and Linagliptin Tablets 10/5mg) and Reference Product (Glyxambi 10/5 mg FCT) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20251010003
Start: 2026-01-12Target: 38Updated: 2026-08-03
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Fixed-dose Combination of Empagliflozin and Linagliptin 10/5 mg Film-coated Tablets (Empiget LT Tablet 10 mg+5 mg) and Reference Product (Glyxambi 10 mg/5 mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20260310010
Start: 2026-06-04Target: 42Updated: 2026-08-03